Industry complaining government's subsidy cut off for new drug R&D.

Published: 2003-03-06 06:58:00

Updated: 2003-03-06 06:58:00

The pharmaceutical industry sensitively concerned about the government budgeting plans for the new drug R&D subsidy to skip. The MOHW budget amounting to the total 89,200 million won for the first half of 2003 did not include any new projects of the new drug R&D.

In fact the MOHW budget allo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK